EGLN3 and neoplasm: Analysis of tumour blood vessels did not reveal a significant difference in vessel density or vessel morphology between control and PHD3-deficient tumours (Supplementary Fig. 4) indicating that the tumour growth-promoting effects of PHD3 loss are independent of the regulation of tumour vascularization.